These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 506801)

  • 1. Dobutamine in left heart failure after acute myocardial infarction.
    Rehnqvist N; Lundman T
    Acta Med Scand; 1979; 206(4):299-302. PubMed ID: 506801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.
    Stopfkuchen H; Schranz D; Huth R; Jüngst BK
    Eur J Pediatr; 1987 Mar; 146(2):135-9. PubMed ID: 3569349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
    Leier CV; Webel J; Bush CA
    Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular responses to dobutamine determined by systolic time intervals in preterm infants.
    Stopfkuchen H; Queisser-Luft A; Vogel K
    Crit Care Med; 1990 Jul; 18(7):722-4. PubMed ID: 2364711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Haemodynamic effect of dobutamine in cardiac failure (author's transl)].
    Delius W; Wirtzfeld A; Sebening H; Mathes P
    Dtsch Med Wochenschr; 1976 Nov; 101(48):1747-51. PubMed ID: 991768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced conditioning in congestive heart failure.
    Leier CV; Huss P; Lewis RP; Unverferth DV
    Circulation; 1982 Jun; 65(7):1382-7. PubMed ID: 7074796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.
    Renard M; Bernard R; Melot C; Jacobs P; Englert M
    Gerontology; 1984; 30(6):408-13. PubMed ID: 6519441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure.
    el Allaf D; Cremers S; D'Orio V; Carlier J
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S49-55. PubMed ID: 6085239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
    Loeb HS; Bredakis J; Gunner RM
    Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of dobutamine in severe congestive heart failure.
    Andy JJ; Curry CL; Ali N; Mehrotra PP
    Am Heart J; 1977 Aug; 94(2):175-82. PubMed ID: 878985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and hemodynamic effects of dobutamine in acute myocardial infarction with left heart failure.
    Renard M; Bernard R
    J Cardiovasc Pharmacol; 1980; 2(5):543-52. PubMed ID: 6157948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dobutamine on isovolumic and ejection phase indices of cardiac contractility in conscious healthy dogs.
    McEntee K; Amory H; Pypendop B; Balligand M; Clercx C; Michaux C; Jacqmot O; Robert F; Gérard P; Pochet T; Henroteaux M
    Res Vet Sci; 1998; 64(1):45-50. PubMed ID: 9557805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.
    Willerson JT; Hutton I; Watson JT; Platt MR; Templeton GH
    Circulation; 1976 May; 53(5):828-33. PubMed ID: 1260986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
    Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
    Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between left ventricular ejection time measurement methods during physiological changes induced by simulated microgravity.
    Orter S; Möstl S; Bachler M; Hoffmann F; Mayer CC; Kaniusas E; Reisinger M; Wassertheurer S; Tank J; Jordan J; Hametner B
    Exp Physiol; 2022 Mar; 107(3):213-221. PubMed ID: 34921742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal systolic time intervals in obesity and their relationship with the amount of overweight.
    Romano M; Carella G; Cotecchia MR; Di Maro T; Indolfi C; Ferro G; Chiariello M
    Am Heart J; 1986 Aug; 112(2):356-60. PubMed ID: 2943149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.
    Roffman DS; Applefeld MM; Grove WR; Talesnick BS; Sutton FJ; Newman KA; Reed WP
    Clin Pharm; 1985; 4(2):195-9. PubMed ID: 3987220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative sensitivity of echocardiography and systolic time intervals for assessing acute positive inotropic interventions in normal human subjects.
    Walsh RA; Crawford MH; O'Rourke RA
    Am Heart J; 1982 Nov; 104(5 Pt 1):1061-70. PubMed ID: 7136998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic time intervals in ischemic and hypertensive heart disease: A comparison of isovolumic relaxation time and rapid filling time with systolic time intervals.
    D'Angelo R; Shah N; Rubler S
    Chest; 1975 Jul; 68(1):56-61. PubMed ID: 1149531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.